5395242026-11-045395242026-11-042026-11-04iso4217:INRxbrli:pure539524Dr. Lal Path Labs Ltd.LALPATHLABNOTLISTEDINE600L01024NewAcquisition (including agreement to acquire)true2026-11-0413:20:002026-11-04Further investment(s) of an amount upto INR 49.5 Crores in Dr. Lal PathLabs FZCO, (“LPL Dubai”), a Wholly Owned Subsidiary of the Company, in one or more tranches, for meeting its business and operational requirements, including making further investment in its subsidiary, Sunshine Healthcare Limited (“SHL”), Ghana.Dr. Lal Path Labs Ltd.Listed Entity (self)Dr. Lal PathLabs FZCO, Dubai200000200000496800000true2026-07-242026-07-24falsetrueLPL Dubai is Wholly Owned Subsidiary of LPL, a related party of LPL. The proposed transactions are in the nature of related party transaction and will be on an arm’s length basis.trueHealthcare DiagnosticsThe proposed investment is intended for meeting business and operational requirements of LPL Dubai, including making further investment in its Subsidiary, SHL.NAtrue31-03-2027Cash495000000Investment of an amount upto INR 49.5 Crores in LPL Dubai. (Including further investment of an amount upto INR 30 Crores in SHL by LPL Dubai)4950000001LPL Dubai was incorporated on June 12, 2026, under the Company Regulations of the DMCC Authority, Dubai, UAE, to strategically invest in Diagnostics and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. SHL was incorporated on September 07, 2010, under the laws of Ghana and is engaged in business of providing Healthcare/ Diagnostics services.Dubai, United Arab Emirates